Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nephrology: renal transplantation].

Undine Ott1, Thomas Steiner, Jörg Schubert

  • 1Klinik für Innere Medizin III, Friedrich-Schiller-Universität Jena, Jena, Deutschland. Undine.Ott@med.uni-jena.de

Medizinische Klinik (Munich, Germany : 1983)
|March 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti-C5 therapy.

HemaSphere·2026
Same author

Genitourinary Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2025: Advances in Renal Cell Carcinoma and Muscle-invasive Bladder Cancer.

Oncology research and treatment·2026
Same author

Zeitschrift fur Rheumatologie·2026
Same author

Associations Between Laboratory-Based Performance Indicators and On-Snow Competitive Success in Elite Cross-Country Skiing: A 15-Year Analysis of the Swiss National Team.

International journal of sports physiology and performance·2026
Same author

Trends in the Management of Bladder Cancer with Emphasis on Frailty: A Nationwide Analysis of More Than 49,000 Patients from a German Hospital Network.

Life (Basel, Switzerland)·2026
Same author

Navigating adulthood with PKU: metabolic outcomes, quality of life, and mental health 4.5 years post-transition.

Orphanet journal of rare diseases·2026

Renal transplantation offers improved quality of life and extended survival for end-stage renal disease patients compared to dialysis. Addressing donor organ shortages and chronic allograft nephropathy are key challenges for successful kidney transplants.

Area of Science:

  • Nephrology
  • Transplantation immunology
  • Public health

Context:

  • Renal replacement therapy is essential for end-stage renal disease (ESRD).
  • Renal transplantation significantly improves patient quality of life and extends survival compared to long-term dialysis.
  • Germany faces a critical shortage of donor kidneys, leading to extended waiting times for ESRD patients.

Purpose:

  • To review current advancements and challenges in renal transplantation.
  • To highlight the importance of expanding the donor pool and managing marginal organs.
  • To emphasize the need for research into chronic allograft nephropathy and personalized immunosuppression.

Summary:

  • Renal transplantation is the optimal renal replacement therapy, with advancements in pathogenesis, diagnostics, and treatment establishing it as a standard procedure.

Related Experiment Videos

  • Despite improvements, donor organ scarcity and extended waiting times pose significant challenges in Germany.
  • Future research focuses on expanding the donor pool, managing marginal organ transplantation, and combating chronic allograft nephropathy.

    • Impact:

    • Optimizing immunosuppressive strategies and developing new monitoring markers are crucial for improving long-term graft and patient survival.
    • Close collaboration between transplant centers, nephrologists, and family doctors is vital for successful post-transplant care.
    • Addressing organ donation rates and refining transplantation criteria will enhance access to this life-extending therapy.